|
Sign In to gain access to subscriptions and/or personal tools.
|
Mitochondrial failures in Alzheimer's disease
Xiongwei Zhu, PhD
Mark A. Smith, PhD
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio.
George Perry, PhD
Gjumrakch Aliev, MD, PhD
Departments of Pathology and the Microscopy Research Center, Case Western Reserve University, Cleveland, Ohio.
Mitochondrial dysfunction and free radical-induced oxidative damage have been implicated in the pathogenesis of several different neurodegenerative diseases such as Parkinson disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), and Alzheimer's disease (AD). The defective adenosine triphosphate (ATP) production and increased oxygen radicals may induce mitochondria-dependent cell death because damaged mitochondria are unable to maintain the energy demands of the cell. The role of vascular hypoperfusion-induced mitochondria failure in the pathogenesis of AD now has been widely accepted. However, the exact cellular mechanisms behind vascular lesions and their relation to oxidative stress markers identified by RNA oxidation, lipid peroxidation, or mitochondrial DNA (mt DNA) deletion remain unknown. Future studies comparing the spectrum of mitochondrial damage and the relationship to oxidative stress-induced damage during the aging process or, more importantly, during the maturation of AD pathology are warranted.
Key Words: mitochondria Alzheimer's disease hypoperfusion mitochondrial DNA deletion amyloid cascade
American Journal of Alzheimer's Disease and Other Dementias®, Vol. 19, No. 6,
345-352 (2004)
DOI: 10.1177/153331750401900611

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Wang, B. Su, H.-g. Lee, X. Li, G. Perry, M. A. Smith, and X. Zhu
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
J. Neurosci.,
July 15, 2009;
29(28):
9090 - 9103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, B. Su, S. L. Siedlak, P. I. Moreira, H. Fujioka, Y. Wang, G. Casadesus, and X. Zhu
Amyloid-{beta} overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins
PNAS,
December 9, 2008;
105(49):
19318 - 19323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Irwin, C. F. Lippa, and J.M. Swearer
Cognition and Amyotrophic Lateral Sclerosis (ALS)
American Journal of Alzheimer's Disease and Other Dementias,
September 1, 2007;
22(4):
300 - 312.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S Parihar and G. J. Brewer
Mitoenergetic failure in Alzheimer disease
Am J Physiol Cell Physiol,
January 1, 2007;
292(1):
C8 - C23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zhu, Y. Lai, P. B. Shelat, C. Hu, G. Y. Sun, and J. C-M. Lee
Phospholipases A2 Mediate Amyloid-beta Peptide-Induced Mitochondrial Dysfunction
J. Neurosci.,
October 25, 2006;
26(43):
11111 - 11119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Devi, B. M. Prabhu, D. F. Galati, N. G. Avadhani, and H. K. Anandatheerthavarada
Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction.
J. Neurosci.,
August 30, 2006;
26(35):
9057 - 9068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Perez, O. Lazarov, J. B. Koprich, E.-Y. Chen, V. Rodriguez-Menendez, J. W. Lipton, S. S. Sisodia, and E. J. Mufson
Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1{Delta}E9 Transgenic Mice
J. Neurosci.,
November 2, 2005;
25(44):
10220 - 10229.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|